Nail changes secondary to docetaxel chemotherapy : a case report.
BACKGROUND
Docetaxel is a chemotherapy agent used in the management of many neoplastic conditions. Various side effects are known. Nail changes are often under-recognised or attributed to other causes.


METHODS
We report the case of a 66 year old gentleman who received docetaxel chemotherapy for non-small cell lung cancer. He had nail changes as a complication of the treatment.


CONCLUSIONS
Nail toxicity is a recognised side-effect of taxane chemotherapy agents and can often persist for many months after finishing the treatment. We would like to highlight this problem, so it can be considered as a differential diagnosis in the appropriate population.
Ghafoor
Qamar
Q
University Hospital Birmingham, Birmingham, UK. qamar.ghafoor@uhb.nhs.uk
Chetiyawardana
Anula
A